I N Todor

666 total citations
38 papers, 563 citations indexed

About

I N Todor is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, I N Todor has authored 38 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Biomaterials and 8 papers in Oncology. Recurrent topics in I N Todor's work include Nanoparticle-Based Drug Delivery (10 papers), Nanoparticles: synthesis and applications (6 papers) and Iron oxide chemistry and applications (3 papers). I N Todor is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), Nanoparticles: synthesis and applications (6 papers) and Iron oxide chemistry and applications (3 papers). I N Todor collaborates with scholars based in Ukraine, Czechia and United States. I N Todor's co-authors include В Ф Чехун, Г. И. Довбешко, G. I. Solyanik, Volodymyr Chegel, Yu.M. Shirshov, N Yu Lukianova, Olga V. Yurchenko, Igor P. Pogribny, Beverly Montgomery and Volodymyr Tryndyak and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Cancer Letters.

In The Last Decade

I N Todor

35 papers receiving 553 citations

Peers

Countries citing papers authored by I N Todor

Since Specialization

Citations

This map shows the geographic impact of I N Todor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I N Todor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I N Todor more than expected).

Fields of papers citing papers by I N Todor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I N Todor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I N Todor. The network helps show where I N Todor may publish in the future.

Co-authorship network of co-authors of I N Todor

This figure shows the co-authorship network connecting the top 25 collaborators of I N Todor. A scholar is included among the top collaborators of I N Todor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I N Todor. I N Todor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Peculiarities of neoplasms appeared after total body irradiation and homeostasis parameters in rats 2022 ·Open Research Europe ·(unknown), (unknown), (unknown), I N Todor, N Yu Lukianova, (unknown), (unknown), (unknown), В Ф Чехун, Nikolaev Vg	1
2	Biomagnetism of tumor in rats with Guerin’s carcinoma after injection of ferromagnetic nanocomposite (Ferroplat): contactless measurement 2020 ·Experimental Oncology ·I N Todor, N Yu Lukianova, (unknown), (unknown), В Ф Чехун	1
3	ANTITUMOR AND GENOTOXIC EFFECTS OF LACTOFERRIN IN WALKER-256 TUMOR-BEARING RATS 2018 ·Experimental Oncology ·В Ф Чехун, (unknown), I N Todor, (unknown), N Yu Lukianova	2
4	INFLUENCE OF FERROMAGNETIC NANOCOMPOSITE (FERROPLAT) ON HUMAN BREAST CANCER CELLS OF DIFFERENT MALIGNANCY DEGREES: PRO/ANTIOXIDANT BALANCE AND ENERGY METABOLISM 2018 ·Experimental Oncology ·В Ф Чехун, I N Todor, N Yu Lukianova, (unknown), (unknown), А.П. Бурлака, (unknown)	1
5	Combined antitumor effect of surface-modified superparamagnetic maghemite nanoparticles and a vitamin E derivative on experimental Walker-256 mammary gland carcinosarcoma 2018 ·Journal of Magnetism and Magnetic Materials ·Beata A. Zasońska, (unknown), (unknown), (unknown), В Ф Чехун, I N Todor, Eduard Petrovský, (unknown), Daniel Horák	3
6	Enhanced antitumor activity of surface-modified iron oxide nanoparticles and an α-tocopherol derivative in a rat model of mammary gland carcinosarcoma 2017 ·International Journal of Nanomedicine ·Daniel Horák, (unknown), (unknown), (unknown), В Ф Чехун, I N Todor, (unknown)	14
7	INFLUENCE OF EXOGENOUS LACTOFERRIN ON THE OXIDANT/ ANTIOXIDANT BALANCE AND MOLECULAR PROFILE OF HORMONE RECEPTOR-POSITIvE AND -NEGATIvE HUMAN BREAST CANCER CELLS IN VITRO 2017 ·Experimental Oncology ·(unknown), N Yu Lukianova, (unknown), А.П. Бурлака, (unknown), (unknown), I N Todor, (unknown), (unknown), В Ф Чехун	8
8	HEPCIDIN AS A POSSIBLE MARKER IN DETERMINATION OF MALIGNANCY DEGREE AND SENSITIVITY OF BREAST CANCER CELLS TO CYTOSTATIC DRUGS 2016 ·Experimental Oncology ·(unknown), I N Todor, N Yu Lukianova, В Ф Чехун	16
9	MODIFYING EFFECTS OF 5-AZACYTIDINE ON METAL-CONTAINING PROTEINS PROFILE IN GUERIN CARCINOMA WITH DIFFERENT SENSITIVITY TO CYTOSTATICS 2016 ·Experimental Oncology ·В Ф Чехун, (unknown), (unknown), (unknown), А.П. Бурлака, I N Todor, (unknown), (unknown), (unknown), (unknown), (unknown), N Yu Lukianova	3
10	PREVENTION OF MYELOSUPPRESSION BY COMBINED TREATMENT WITH ENTEROSORBENT AND GRANULOCYTE COLONY-STIMULATING FACTOR 2015 ·Experimental Oncology ·(unknown), (unknown), I N Todor, N Yu Lukianova, Nikolaev Vg, В Ф Чехун	5
11	Improved Synthesis of N-Benzylaminoferrocene-Based Prodrugs and Evaluation of Their Toxicity and Antileukemic Activity 2015 ·Journal of Medicinal Chemistry ·Steffen Daum, В Ф Чехун, I N Todor, N Yu Lukianova, (unknown), Leopold Sellner, Kerstin Putzker, Joe Lewis, Thorsten Zenz, Inge A.M. de Graaf, Geny M. M. Groothuis, Angela Casini, Oleksii Zozulia, Frank Hampel, Andriy Mokhir	75
12	Assessment of the geno- and cytotoxic action of colloidal gold nanoparticles on the bone marrow erythroid cell lines and tumors in animals with Ehrlich ascites carcinoma 2015 ·Cytology and Genetics ·(unknown), (unknown), (unknown), I N Todor, В Ф Чехун	3
13	Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor. 2014 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), I N Todor, В Ф Чехун	1
14	Microspectroscopic Study of Liposome-to-cell Interaction Revealed by Förster Resonance Energy Transfer 2013 ·Journal of Fluorescence ·Svetlana Yefimova, (unknown), T. N. Tkacheva, Nataliya Kavok, I N Todor, N Yu Lukianova, В Ф Чехун, Yu. V. Malyukin	8
15	Inter-laboratory comparison of turkey in ovo carcinogenicity assessment (IOCA) of hepatocarcinogens 2012 ·Experimental and Toxicologic Pathology ·(unknown), Klaus D. Brunnemann, Michael J. Iatropoulos, Svitlana Shpyleva, (unknown), I N Todor, Malcolm A Moore, Karsten Spicher, В Ф Чехун, Hiroyuki Tsuda, Gary M. Williams	8
16	Ultrastructural and some functional changes in tumor cells treated with stabilized iron oxide nanoparticles. 2010 ·PubMed ·Olga V. Yurchenko, I N Todor, (unknown), (unknown), N Yu Lukianova, В Ф Чехун	8
17	Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards cis-DDP resistance. 2007 ·PubMed ·(unknown), (unknown), (unknown), (unknown), I N Todor, G. I. Solyanik	16
18	Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells 2005 ·Cancer Letters ·В Ф Чехун, (unknown), Olga V. Yurchenko, Volodymyr Tryndyak, I N Todor, (unknown), (unknown), (unknown), Beverly Montgomery, Natalia Rusetska, Igor P. Pogribny	65
19	Structural organisation of nucleic acids from tumour cells 2003 ·Faraday Discussions ·(unknown), Г. И. Довбешко, (unknown), I N Todor, Dmytro Kosenkov	18
20	Surface enhanced IR absorption of nucleic acids from tumor cells: FTIR reflectance study 2002 ·Biopolymers ·Г. И. Довбешко, Volodymyr Chegel, (unknown), (unknown), Yu.M. Shirshov, (unknown), I N Todor, G. I. Solyanik	171

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact